$GRST
ETHEMA HEALTH Corp Stock $grst

$grst Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000190359624000678 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$1.760M	$1.354M
YoY Change		29.99%	-4.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin			$1.210M
YoY Change			17.11%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$33.23K	$20.69K
YoY Change		60.59%	-84.85%
% of Gross Profit
Operating Expenses		$2.484M	$1.320M
YoY Change		88.11%	12.86%
Operating Profit		-$723.7K	$33.53K
YoY Change		-2258.52%	-86.85%
Interest Expense			-$148.6K
YoY Change			-174.91%
% of Operating Profit			-443.3%
Other Income/Expense, Net			$110.00
YoY Change			-110.53%
Pretax Income		-$1.001M	$2.092M
YoY Change		-147.84%	275.76%
Income Tax			-$15.53K
% Of Pretax Income			-0.74%
Net Earnings			$2.108M
YoY Change			311.56%
Net Earnings / Revenue			155.66%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share		$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	7.729B shares	7.729B shares	3.729B shares
Diluted Shares Outstanding		7.207B shares	3.931B shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$11.73K
YoY Change		-97.91%
Cash & Equivalents	$60.86K	$11.73K
Short-Term Investments
Other Short-Term Assets	$1.478K	$62.65K
YoY Change	-97.64%	-7.45%
Inventory
Prepaid Expenses	$28.78K	$39.07K
Receivables	$381.3K	$681.1K
Other Receivables		$0.00
Total Short-Term Assets	$472.4K	$794.5K
YoY Change	-40.54%	-17.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$756.4K	$523.7K
YoY Change	44.43%	-82.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$374.0K
YoY Change		7806.98%
Total Long-Term Assets	$11.84M	$11.21M
YoY Change	5.62%	94.38%
TOTAL ASSETS
Total Short-Term Assets	$472.4K	$794.5K
Total Long-Term Assets	$11.84M	$11.21M
Total Assets	$12.32M	$12.01M
YoY Change	2.57%	78.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$129.4K
YoY Change		-63.17%
Accrued Expenses		$32.75K
YoY Change		-88.11%
Deferred Revenue
YoY Change
Short-Term Debt	$2.466M	$124.9K
YoY Change	1874.62%	-60.68%
Long-Term Debt Due		$23.21K
YoY Change		-99.35%
Total Short-Term Liabilities	$7.541M	$7.713M
YoY Change	-2.23%	-44.99%
LONG-TERM LIABILITIES
Long-Term Debt		$291.7K
YoY Change		-53.74%
Other Long-Term Liabilities		$9.339M
YoY Change		629.55%
Total Long-Term Liabilities	$11.91M	$9.802M
YoY Change	21.5%	360.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.541M	$7.713M
Total Long-Term Liabilities	$11.91M	$9.802M
Total Liabilities	$19.45M	$17.51M
YoY Change	11.05%	8.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$44.09M	-$41.96M
YoY Change	5.08%	-4.77%
Common Stock	$77.29M	$37.29M
YoY Change	107.27%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.134M	-$5.507M
YoY Change
Total Liabilities & Shareholders Equity	$12.32M	$12.01M
YoY Change	2.57%	78.45%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income		$2.108M
YoY Change		311.56%
Depreciation, Depletion And Amortization	$33.23K	$20.69K
YoY Change	60.59%	-84.85%
Cash From Operating Activities		-$615.8K
YoY Change		-179.75%
INVESTING ACTIVITIES
Capital Expenditures		$5.224M
YoY Change		-7419.62%
Acquisitions
YoY Change
Other Investing Activities		$7.719M
YoY Change		-15538.9%
Cash From Investing Activities		$2.495M
YoY Change		-2156.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-1.890M
YoY Change		-810.59%
NET CHANGE
Cash From Operating Activities		-615.8K
Cash From Investing Activities		2.495M
Cash From Financing Activities		-1.890M
Net Change In Cash		-10.03K
YoY Change		-101.09%
FREE CASH FLOW
Cash From Operating Activities		-$615.8K
Capital Expenditures		$5.224M
Free Cash Flow		-$5.840M
YoY Change		-792.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	ETHEMA HEALTH CORPORATION.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1227328
	dei	Entity Address Address Line1 EntityAddressAddressLine1	950 Evernia Street
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
	dei	City Area Code CityAreaCode	416
	dei	Local Phone Number LocalPhoneNumber	500-0020
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	46000	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	40000	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54748
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	us-gaap	Loan Processing Fee LoanProcessingFee		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3729053805	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3729053805	shares
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1000670	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	244275	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	756395	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	508401	usd
CY2024Q3	us-gaap	Depreciation Depreciation	33226	usd
CY2023Q3	us-gaap	Depreciation Depreciation	20690	usd
	us-gaap	Depreciation Depreciation	77528	usd
	us-gaap	Depreciation Depreciation	119774	usd
CY2024Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1789903	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1163436	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	626467	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	894952	usd
CY2024Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	89495	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	89495	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	268485	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	268485	usd
CY2024Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	18496	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	26889	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9988784	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9323723	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	8392	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	8392	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1106	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1504	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	9498	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	9896	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	910076	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	446189	usd
	us-gaap	Lease Cost LeaseCost	919574	usd
	us-gaap	Lease Cost LeaseCost	456085	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1106	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1504	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	738760	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	446189	usd
	GRST	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	-6266	usd
	GRST	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	-5868	usd
	GRST	Financing Cash Flows From Finance Leases Net FinancingCashFlowsFromFinanceLeasesNet	-746132	usd
	GRST	Financing Cash Flows From Finance Leases Net FinancingCashFlowsFromFinanceLeasesNet	-453561	usd
	GRST	Weighted Average Lease Term Finance Leases WeightedAverageLeaseTermFinanceLeases	2 years and 2 months
	GRST	Weighted Average Lease Term Finance Leases WeightedAverageLeaseTermFinanceLeases	3 years and 2 months
	GRST	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	17 years and ten months
	GRST	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	19 years and 11 months
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0658	pure
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0660	pure
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0760	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0770	pure
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2457	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	9829	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	6195	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1707	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	20188	usd
CY2024Q3	GRST	Imputed Interest ImputedInterest	-1591	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	18597	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8861	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9736	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	18597	usd
CY2024Q3	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	257672	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1045192	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1074288	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	961526	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	841379	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	15358663	usd
CY2024Q3	GRST	Total Undiscounted Minimum Future Lease Payments TotalUndiscountedMinimumFutureLeasePayments	19538720	usd
CY2024Q3	GRST	Imputed Interest1 ImputedInterest1	-9277365	usd
CY2024Q3	GRST	Lessee Operating Lease Liability Payments Due One LesseeOperatingLeaseLiabilityPaymentsDueOne	10261355	usd
CY2024Q3	GRST	Operating Leases Liability Current OperatingLeasesLiabilityCurrent	287128	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9974227	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	10261355	usd
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2969776	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	968155	usd
CY2024Q3	us-gaap	Debt Current DebtCurrent	3937931	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	4419927	usd
CY2024Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2188631	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	4419927	usd
CY2024Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1749300	usd
CY2024Q3	us-gaap	Debt Current DebtCurrent	3937931	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0000792935
CY2023Q4	us-gaap	Long Term Commercial Paper Current LongTermCommercialPaperCurrent		usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2023Q4	us-gaap	Commercial Paper Noncurrent CommercialPaperNoncurrent		usd
CY2024Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2024Q3	GRST	Penalty On Convertible Debt PenaltyOnConvertibleDebt		usd
CY2023Q3	GRST	Penalty On Convertible Debt PenaltyOnConvertibleDebt		usd
	GRST	Penalty On Convertible Debt PenaltyOnConvertibleDebt		usd
CY2024Q3	us-gaap	Loan Processing Fee LoanProcessingFee		usd
	us-gaap	Loan Processing Fee LoanProcessingFee		usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2024Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2024Q3	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther		usd
CY2023Q3	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther		usd
	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther		usd
	us-gaap	Management Fee Expense ManagementFeeExpense		usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
	GRST	Penalty On Convertible Promissory Notes PenaltyOnConvertiblePromissoryNotes		usd
	GRST	Deferred Tax Movement DeferredTaxMovement		usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable		usd
	GRST	Proceeds On Disposal Of Property ProceedsOnDisposalOfProperty		usd
	GRST	Acquisition Of Business AcquisitionOfBusiness		usd
	GRST	Acquisition Of Minority Shareholder Interest AcquisitionOfMinorityShareholderInterest		usd
	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	GRST	Repayment Of Related Party Advance RepaymentOfRelatedPartyAdvance		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Notes Issued1 NotesIssued1		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1		usd
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate		usd
	us-gaap	Notes Assumed1 NotesAssumed1		usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent		usd
CY2023Q4	GRST	Debt Discount At Inception DebtDiscountAtInception		usd
CY2023Q4	GRST	Amortization Of Debt Discount AmortizationOfDebtDiscount		usd
CY2023Q4	GRST	Total Debt Discount TotalDebtDiscount		usd
CY2023Q4	GRST	Related Party Advance RelatedPartyAdvance		usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	GRST	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	GRST	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	GRST	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	GRST	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7729053805	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	60862	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68573	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	381307	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	313338	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	28777	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18159	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1478	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3030	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	472424	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	4419927	usd
	GRST	Debt Instrument Of Principal Amount DebtInstrumentOfPrincipalAmount	2400543	usd
	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	124078	usd
	GRST	Debt Instrument Unamortized Discounts DebtInstrumentUnamortizedDiscounts	-58603	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2466018	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	680672	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	403100	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	756395	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	508401	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	626467	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	894952	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9988784	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9323723	usd
CY2024Q3	us-gaap	Deposit Contracts Assets DepositContractsAssets	472393	usd
CY2023Q4	us-gaap	Deposit Contracts Assets DepositContractsAssets	389000	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	11844039	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	11116076	usd
CY2024Q3	us-gaap	Assets Assets	12316463	usd
CY2023Q4	us-gaap	Assets Assets	11519176	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	566984	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	352101	usd
CY2024Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2188631	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	4419927	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	2466018	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	680672	usd
CY2024Q3	us-gaap	Long Term Commercial Paper Current LongTermCommercialPaperCurrent	267500	usd
CY2024Q3	GRST	Receivables Funding ReceivablesFunding	480573	usd
CY2023Q4	GRST	Receivables Funding ReceivablesFunding	211961	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	253596	usd
CY2024Q3	us-gaap	Government Assistance Liability Current GovernmentAssistanceLiabilityCurrent	15078	usd
CY2023Q4	us-gaap	Government Assistance Liability Current GovernmentAssistanceLiabilityCurrent	14962	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	287128	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38563	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8861	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8426	usd
CY2024Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1006929	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	2572292	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7541298	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8298904	usd
CY2024Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1749300	usd
CY2024Q3	us-gaap	Commercial Paper Noncurrent CommercialPaperNoncurrent	167500	usd
CY2024Q3	us-gaap	Government Assistance Liability Noncurrent GovernmentAssistanceLiabilityNoncurrent	8874	usd
CY2023Q4	us-gaap	Government Assistance Liability Noncurrent GovernmentAssistanceLiabilityNoncurrent	20520	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9974227	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9383557	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9736	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	16475	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	11909637	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9420552	usd
CY2024Q3	us-gaap	Liabilities Liabilities	19450935	usd
CY2023Q4	us-gaap	Liabilities Liabilities	17719456	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4600000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4600000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7729053805	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7729053805	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	77290539	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	37290539	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24986083	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26187925	usd
CY2024Q3	GRST	Discount For Shares Issued Amount DiscountForSharesIssuedAmount	-65363367	usd
CY2023Q4	GRST	Discount For Shares Issued Amount DiscountForSharesIssuedAmount	-27363367	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44093727	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42355377	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7134472	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6200280	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12316463	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11519176	usd
CY2024Q3	us-gaap	Revenues Revenues	1760000	usd
CY2023Q3	us-gaap	Revenues Revenues	1353899	usd
	us-gaap	Revenues Revenues	4550200	usd
	us-gaap	Revenues Revenues	4219904	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	417888	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	249283	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1055663	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	755685	usd
CY2024Q3	GRST	Payments For Rents PaymentsForRents	392772	usd
CY2023Q3	GRST	Payments For Rents PaymentsForRents	107707	usd
	GRST	Payments For Rents PaymentsForRents	932035	usd
	GRST	Payments For Rents PaymentsForRents	328204	usd
CY2024Q3	GRST	Management Fee Expenses ManagementFeeExpenses	480000	usd
CY2023Q3	GRST	Management Fee Expenses ManagementFeeExpenses	30000	usd
	GRST	Management Fee Expenses ManagementFeeExpenses	480000	usd
	GRST	Management Fee Expenses ManagementFeeExpenses	273003	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	231312	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	171659	usd
	us-gaap	Professional Fees ProfessionalFees	686994	usd
	us-gaap	Professional Fees ProfessionalFees	460773	usd
CY2024Q3	us-gaap	Salaries And Wages SalariesAndWages	839015	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	651537	usd
	us-gaap	Salaries And Wages SalariesAndWages	2279788	usd
	us-gaap	Salaries And Wages SalariesAndWages	1873280	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	122721	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	110185	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	346013	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	388259	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2483708	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1320371	usd
	us-gaap	Operating Expenses OperatingExpenses	5780493	usd
	us-gaap	Operating Expenses OperatingExpenses	4079204	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-723708	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	33528	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1230293	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	140700	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	40000	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	110	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	40000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	449	usd
CY2024Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	971	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	971	usd
	GRST	Penalty On Convertible Debt PenaltyOnConvertibleDebt	34688	usd
	us-gaap	Loan Processing Fee LoanProcessingFee	130000	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2484172	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2484172	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-277175	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-277175	usd
CY2024Q3	us-gaap	Interest Income Other InterestIncomeOther	766	usd
	us-gaap	Interest Income Other InterestIncomeOther	1864	usd
CY2024Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	167575	usd
CY2023Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	81371	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	367675	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	382448	usd
CY2024Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	141205	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	73857	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	279607	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	238304	usd
CY2024Q3	GRST	Foreign Exchange Movements ForeignExchangeMovements	8021	usd
CY2023Q3	GRST	Foreign Exchange Movements ForeignExchangeMovements	-6598	usd
	GRST	Foreign Exchange Movements ForeignExchangeMovements	3510	usd
	GRST	Foreign Exchange Movements ForeignExchangeMovements	84148	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1000714	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2092005	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1840192	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1478558	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15532	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-221107	usd
CY2024Q3	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	-1000714	usd
CY2023Q3	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	2107537	usd
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	-1840192	usd
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	1699665	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	31058	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-101842	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	127906	usd
CY2024Q3	GRST	Net Income Loss Stockholders NetIncomeLossStockholders	-1000714	usd
CY2023Q3	GRST	Net Income Loss Stockholders NetIncomeLossStockholders	2076479	usd
	GRST	Net Income Loss Stockholders NetIncomeLossStockholders	-1738350	usd
	GRST	Net Income Loss Stockholders NetIncomeLossStockholders	1571759	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	47225	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1000714	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2076479	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1738350	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1524534	usd
	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther	-5065	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1000714	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2076479	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1738350	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1529599	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q3	GRST	Loss Income Per Share LossIncomePerShare	-0.00
CY2023Q3	GRST	Loss Income Per Share LossIncomePerShare	0.00
	GRST	Loss Income Per Share LossIncomePerShare	-0.00
	GRST	Loss Income Per Share LossIncomePerShare	0.00
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7207314674	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3729053805	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4896937017	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3729053805	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7207314674	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3931379775	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4896937017	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3931379775	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-6200280	usd
CY2024Q1	GRST	Net Incomes Loss NetIncomesLoss	-374203	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-6574483	usd
CY2024Q2	us-gaap	Stock Option Down Round Feature Increase Decrease In Equity Amount1 StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount1	-1100000	usd
CY2024Q2	GRST	Net Incomes Loss NetIncomesLoss	-465275	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-8139758	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	2006000	usd
CY2024Q3	GRST	Net Incomes Loss NetIncomesLoss	-1000714	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-7134472	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9232543	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-1504	usd
CY2023Q1	GRST	Net Incomes Loss NetIncomesLoss	-175717	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	23419	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-9433183	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1334885	usd
CY2023Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	461184	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	6569	usd
CY2023Q2	GRST	Net Incomes Loss NetIncomesLoss	232155	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	23806	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-7886506	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	271939	usd
CY2023Q3	GRST	Net Incomes Loss NetIncomesLoss	2107537	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5507030	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1840192	usd
	us-gaap	Net Income Loss NetIncomeLoss	1699665	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	346013	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	388259	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	279607	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	238304	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	480000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	79196	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	169682	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	2484172	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-277175	usd
	GRST	Penalty On Convertible Promissory Notes PenaltyOnConvertiblePromissoryNotes	34688	usd
	GRST	Deferred Tax Movement DeferredTaxMovement	46597	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-62671	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	289697	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9066	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	48457	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	128838	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-110110	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	94979	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-167319	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-237211	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-377954	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-575790	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	85522	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5244011	usd
	GRST	Proceeds On Disposal Of Property ProceedsOnDisposalOfProperty	8093448	usd
	GRST	Acquisition Of Business AcquisitionOfBusiness	240000	usd
	GRST	Acquisition Of Minority Shareholder Interest AcquisitionOfMinorityShareholderInterest	625000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	83393	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	374000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1033915	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2475437	usd
	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	58320	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	150000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1124442	usd
	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	1912000	usd
	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	223500	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	801323	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	568325	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	40000	usd
	GRST	Repayment Of Government Assistance Loans RepaymentOfGovernmentAssistanceLoans	11519	usd
	GRST	Repayment Of Government Assistance Loans RepaymentOfGovernmentAssistanceLoans	10855	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	361260	usd
	us-gaap	Repayments Of Construction Loans Payable RepaymentsOfConstructionLoansPayable	6304	usd
	us-gaap	Repayments Of Construction Loans Payable RepaymentsOfConstructionLoansPayable	5907	usd
	GRST	Proceeds From Receivables Funding ProceedsFromReceivablesFunding	542000	usd
	GRST	Proceeds From Receivables Funding ProceedsFromReceivablesFunding	580646	usd
	GRST	Repayment Of Receivables Funding RepaymentOfReceivablesFunding	378688	usd
	GRST	Repayment Of Receivables Funding RepaymentOfReceivablesFunding	848417	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
	GRST	Repayment Of Related Party Advance RepaymentOfRelatedPartyAdvance	11538	usd
	GRST	Repayment Of Related Party Notes RepaymentOfRelatedPartyNotes	39363	usd
	GRST	Repayment Of Related Party Notes RepaymentOfRelatedPartyNotes	76296	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1415265	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2099676	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-11107	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7711	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-129029	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68573	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140757	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60862	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11728	usd
	us-gaap	Interest Paid Net InterestPaidNet	248079	usd
	us-gaap	Interest Paid Net InterestPaidNet	334735	usd
	us-gaap	Notes Issued1 NotesIssued1	475000	usd
	us-gaap	Stock Issued1 StockIssued1	2000000	usd
	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1	6000	usd
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	1334885	usd
	us-gaap	Notes Assumed1 NotesAssumed1	461184	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_803_eus-gaap--NatureOfOperations_zPplq4CeXNqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82F_zRl78rfKyNFj">Nature of business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="background-color: white">Since 2010, the Company has operated addiction treatment centers. Initially the Company operated an addiction treatment center in Ontario Canada under its Greenestone Muskoka clinic, which was sold on February 14, 2017. Simultaneously with this sale the Company purchased buildings and operated an addiction treatment center in Delray Beach Florida under its Addiction recovery Institute of America subsidiary with a license obtained in December 2016, initially through owned properties in Delray Beach and subsequently through leased properties in West Palm Beach, Florida. Since June 30, 2020, the Company has been actively involved in the management of a treatment center operated by Evernia in West Palm Beach Florida. On July 1, 2021, the Company closed on the acquisition of 75% of ATHI, which owns 100% of Evernia, once the probationary approval of a license was obtained from the Department of Children and Family Services of Florida. The Company’s operations are currently conducted through its Evernia West Palm Beach facility and operations are expected to commence in its Boca Raton facility as soon as the facility is approved for patient intake by insurers, which approval is expected in the fourth quarter of 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="background-color: white"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="background-color: white">The Company sold its real estate on which its Greenstone Muskoka clinic operated during the prior year.</span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="background-color: white"><b><i>Acquisition of minority shareholders interest in ATHI</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="background-color: white">On May 15, 2024, the Company entered into a Stock Purchase Agreement whereby it acquired the remaining 25% of ATHI representing 5,000,000 shares from the minority shareholder for gross proceeds of $1,100,000. The Company paid an initial deposit of $25,000 and on closing an additional $600,000. The Company issued a non-interest-bearing promissory note for the remaining balance of $475,000, which promissory note is repayable in installments of $10,000 a month on each monthly anniversary date of the agreement for months one to eight (eight installments) and months ten through seventeen (eight installments), and payments of $157,500 on month nine and month eighteen, for a total of $475,000. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="background-color: white"><b><i>Acquisition of assets and assignment of lease and sub-lease for Boca cove Detox Center</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="background-color: white">On March 22, 2024, the Company executed a LOI to acquire certain assets, including furniture, equipment inventory and supplies of Boca Cove Detox, LLC, along with the assignment of lease and sub-lease for premises located at 899 Meadow Avenue, Boca Raton, Florida. On May 1, 2024 the Company, through its subsidiary Evernia Health Center LLC, entered into a Definitive Agreement whereby the Company would assume the lease for suites 100,101, 201, 202 and 203 located at 899 Meadows Road, Boca Raton, Florida (the “Leased Premises”) and the furniture, fixtures and equipment located therein, upon the assignment of the lease from the property owner. The lease was assigned on June 10, 2024 and the Company entered into a Bill of Sale to give effect to the Definitive Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="background-color: white">The purchase price was $240,000 which was settled by a deposit of $20,000 and a cash payment of $220,000 and the payment to the Seller of $83,393 for the assumption of the security deposit held by the landlord of the Leased Premises located at 899 Meadows Road.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="background-color: white"> </span></span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zc8B2F2VYqZk" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a) <span id="xdx_862_z7ROUPyBzcC5">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Fdic Indemnification Asset FDICIndemnificationAsset	250000	usd
CY2024Q3	us-gaap	Other Receivables OtherReceivables	381307	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	313338	usd
CY2024Q3	GRST	Working Capital WorkingCapital	7100000	usd
CY2024Q3	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	-44100000	usd
CY2024Q3	GRST	Working Capital WorkingCapital	7100000	usd
CY2024Q3	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	7100000	usd
	GRST	Purchase Price PurchasePrice	5500000	usd
	GRST	Fees And Expenses Related To Property Purchase FeesAndExpensesRelatedToPropertyPurchase	109276	usd
	us-gaap	Acquisition Costs AcquisitionCosts	5609276	usd
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	8500000	usd
	GRST	Fees And Expenses Related To Disposal Of Property FeesAndExpensesRelatedToDisposalOfProperty	-406552	usd
	us-gaap	Gain Loss On Sale Of Unproved Property GainLossOnSaleOfUnprovedProperty	8093448	usd
	us-gaap	Gain Loss On Sale Of Property GainLossOnSaleOfProperty	2484172	usd
CY2024Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1006929	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	2572292	usd
CY2024Q3	GRST	Debt Discount At Inception DebtDiscountAtInception	-35000	usd
CY2024Q3	GRST	Amortization Of Debt Discount AmortizationOfDebtDiscount	15135	usd
CY2024Q3	GRST	Total Debt Discount TotalDebtDiscount	-19865	usd
CY2024Q3	GRST	Related Party Advance RelatedPartyAdvance	253596	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	602852506	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.001306
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	745810761	shares
CY2023	GRST	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice	0.001
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.001
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	326286847	shares
CY2023	GRST	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePrice	0.000675
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.000675
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1022376420	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0012840
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1022376420	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0012840
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	0	usd
CY2024Q3	GRST	Shares Issuable Upon Exercise Of Warrants SharesIssuableUponExerciseOfWarrants	1022376420	shares
	GRST	Shares Issuable Upon Exercise Of Warrants SharesIssuableUponExerciseOfWarrants	1022376420	shares
CY2024Q3	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	177521610	shares
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	177521610	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1199898030	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1199898030	shares
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2076479	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3729053805	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q3	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	50964	usd
CY2023Q3	GRST	Warrants Shares WarrantsShares	202325970	shares
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2127443	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3931379775	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1524534	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3729053805	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	146395	usd
	GRST	Warrants Shares WarrantsShares	202325970	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1670929	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3931379775	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001903596-24-000678-index-headers.html	Edgar Link	pending
0001903596-24-000678-index.html	Edgar Link	pending
0001903596-24-000678.txt	Edgar Link	pending
0001903596-24-000678-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
grst-20240930.xsd	Edgar Link	pending
grst_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
grst-20240930_cal.xml	Edgar Link	unprocessable
grst-20240930_def.xml	Edgar Link	unprocessable
grst-20240930_lab.xml	Edgar Link	unprocessable
grst-20240930_pre.xml	Edgar Link	unprocessable
grst_10q_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRST
ETHEMA HEALTH Corp Stock $grst

2024 Q4 Form 10-Q Financial Statement

#000190359624000678 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRST ETHEMA HEALTH Corp Stock $grst

2024 Q4 Form 10-Q Financial Statement

#000190359624000678 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRST
ETHEMA HEALTH Corp Stock $grst